Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update
Author:
Affiliation:
1. Pharmacy, Intermountain Primary Children's Hospital; Salt Lake City Utah
2. Intermountain Cystic Fibrosis Pediatric Center; Salt Lake City Utah
3. Mayo Clinic; Jacksonville Florida
4. University of Utah College of Pharmacy; Salt Lake City Utah
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.23713/fullpdf
Reference8 articles.
1. Optimization of anti-pseudomonal antibiotics for in cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins;Zobell;Pediatr Pulmonol,2013
2. 2015
3. Population pharmacokinetics and safety of ceftolozane-tazobactam in adult cystic fibrosis patients admitted with acute pulmonary exacerbation;Monogue;Antimicrob Agents Chemother,2016
4. Follow-up survey of the utilization of anti-pseudomonal beta-lactam antibiotics at U.S. Cystic Fibrosis Centers;Fischer;Pediatr Pulmonol,2016
5. Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients;Zamorano;Clin Microbiol Infect,2010
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?;Biomolecules;2023-02-10
2. New concepts in antimicrobial resistance in cystic fibrosis respiratory infections;Journal of Cystic Fibrosis;2022-11
3. Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review;International Journal of Antimicrobial Agents;2021-09
4. The indispensable role of pharmacy services and medication therapy management in cystic fibrosis;Pediatric Pulmonology;2021-08-11
5. Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem‐vaborbactam and cefiderocol;Pediatric Pulmonology;2021-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3